624 related articles for article (PubMed ID: 17018806)
21. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
22. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
[TBL] [Abstract][Full Text] [Related]
23. Moderation of antidepressant response by the serotonin transporter gene.
Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
[TBL] [Abstract][Full Text] [Related]
24. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.
Nonen S; Kato M; Takekita Y; Wakeno M; Sakai S; Serretti A; Kinoshita T
J Clin Psychopharmacol; 2016 Feb; 36(1):27-31. PubMed ID: 26674707
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
27. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.
Keers R; Uher R; Huezo-Diaz P; Smith R; Jaffee S; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Zobel A; Hauser J; Souery D; Placentino A; Larsen ER; Dmitrzak-Weglarz M; Gupta B; Hoda F; Craig I; McGuffin P; Farmer AE; Aitchison KJ
Pharmacogenomics J; 2011 Apr; 11(2):138-45. PubMed ID: 20212518
[TBL] [Abstract][Full Text] [Related]
28. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.
Hong CJ; Chen TJ; Yu YW; Tsai SJ
Pharmacogenomics J; 2006; 6(1):27-33. PubMed ID: 16302021
[TBL] [Abstract][Full Text] [Related]
29. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
[TBL] [Abstract][Full Text] [Related]
30. Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.
Bousman CA; Sarris J; Won ES; Chang HS; Singh A; Lee HY; Ham BJ; Tan CH; Lee MS; Ng CH
J Clin Psychopharmacol; 2014 Oct; 34(5):645-8. PubMed ID: 24943391
[TBL] [Abstract][Full Text] [Related]
31. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
[TBL] [Abstract][Full Text] [Related]
32. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
33. Association Study Between Serotonin Transporter Gene and Fluoxetine Response in Mexican Patients With Major Depressive Disorder.
Camarena B; Álvarez-Icaza D; Hernández S; Aguilar A; Münch L; Martínez C; Becerra-Palars C
Clin Neuropharmacol; 2019; 42(1):9-13. PubMed ID: 30520759
[TBL] [Abstract][Full Text] [Related]
34. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
[TBL] [Abstract][Full Text] [Related]
35. Genetic prediction of antidepressant drug response and nonresponse in Korean patients.
Lim SW; Won HH; Kim H; Myung W; Kim S; Kim KK; Carroll BJ; Kim JW; Kim DK
PLoS One; 2014; 9(9):e107098. PubMed ID: 25226239
[TBL] [Abstract][Full Text] [Related]
36. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
[TBL] [Abstract][Full Text] [Related]
37. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
38. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder.
Ramesh V; Venkatesan V; Ramasamy B
Hum Psychopharmacol; 2022 Jul; 37(4):e2830. PubMed ID: 34994008
[TBL] [Abstract][Full Text] [Related]
39. Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.
Zhang H; Smith GN; Liu X; Holden JJ
Physiol Genomics; 2010 Jun; 42(1):85-92. PubMed ID: 20332182
[TBL] [Abstract][Full Text] [Related]
40. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
